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Obesity promotes systemic insulin resistance
through inflammatory changes that lead to the
release of cytokines from activated macrophages.
Although the mechanism is unclear, the second
messenger cAMP has been found to attenuate
macrophage activity in response to a variety of
hormonal signals. We show that, in the setting of
acute overnutrition, leptin triggers catecholamine-
dependent increases in cAMP signaling that reduce
inflammatory gene expression via the activation of
the histone deacetylase HDAC4. cAMP stimulates
HDAC4 activity through the PKA-dependent inhibi-
tion of the salt-inducible kinases (SIKs), which
otherwise phosphorylate and sequester HDAC4 in
the cytoplasm. Following its dephosphorylation,
HDAC4 shuttles to the nucleus where it inhibits
NF-kB activity over proinflammatory genes. As vari-
ants in the Hdac4 gene are associated with obesity
in humans, our results indicate that the cAMP-
HDAC4 pathway functions importantly in maintaining
insulin sensitivity and energy balance via its effects
on the innate immune system.
INTRODUCTION
Obesity is associated with a chronic inflammatory state that con-
tributes to the development of insulin resistance (Hotamisligil,
2006). Activation of the inhibitor of kappa B kinase b (IKKb) in
macrophages stimulates the release of inflammatory mediators
that promote insulin resistance (Arkan et al., 2005; Yuan et al.,
2001); indeed, disruption of NF-kB activity through deletion of
IKKb increases insulin sensitivity (Arkan et al., 2005).
The second messenger cAMP has been found to exert potent
anti-inflammatory effects on macrophage function through in-1058 Cell Metabolism 19, 1058–1065, June 3, 2014 ª2014 Elsevier Induction of the Ser/Thr kinase PKA (Aronoff et al., 2005). A num-
ber of bacteria including Mycobacterium tuberculosis (Agarwal
et al., 2009) and Bacillus anthracis (Tang and Guo, 2009) have
been shown to evade the immune system by stimulating cAMP
production.
cAMP regulates cellular gene expression via activation of the
CREB/CRTC pathway and via induction of class II HDACs (Altar-
ejos and Montminy, 2011; Mihaylova et al., 2011; Wang et al.,
2011). In the basal state, CRTCs and class IIa HDACs are both
sequestered in the cytoplasm through phosphorylation by salt-
inducible kinases (SIKs). Exposure to cAMP agonist inhibits
SIK activity through PKA-mediated phosphorylation, leading to
their dephosphorylation and nuclear entry. Here we explore the
role of both pathways in mediating anti-inflammatory effects of
catecholamines on cytokine gene expression. We found a domi-
nant role for one of these in downregulating NF-kB activity in
macrophages, particularly in the setting of overnutrition. Our
results point to new potential approaches for the treatment of
individuals with insulin resistance.RESULTS AND DISCUSSION
We tested acute effects of cAMP on the inflammatory response
to bacterial lipopolysaccharide (LPS). Administration of LPS
(30 mg/kg) into adult C57BL/6J mice increased circulating con-
centrations of the proinflammatory cytokines (TNF-a, IL-12b)
and promoted lethality within 1–2 days (Figures 1A, 1B, and
S1A). Coadministration of the phospho-diesterase 4 (PDE4) in-
hibitor rolipram (5 mg/kg) blocked effects of LPS on cytokine
release and survival (Figures 1 and S1) (Herve´ et al., 2008). More-
over, exposure of cultured bone marrow macrophages (BMMs)
to prostaglandin E2 (PGE2), a paracrine hormone that stimulates
cAMP production (Okonogi et al., 1991), reduced proinflamma-
tory cytokine mRNA amounts and secretion from cultured cells
exposed to LPS (Figures 1C, 1D, and S1B). We observed similar
effects using the b2-adrenergic receptor agonist isoproterenol or
the cell-permeable cAMP analog 8-Br-cAMP. In keeping with
their stimulatory effects on the cAMP pathway, exposure ofc.
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Figure 1. Anti-inflammatory Effects of cAMP in Macrophages
(A and B) Effect of intraperitoneal (i.p.) LPS (30 mg/kg) on survival (A) and circulating cytokine concentrations (B) in 12-week-old C57BL/6J mice. Coinjection of
phospho-diesterase inhibitor rolipram (5 mg/kg) indicated (n = 8; *p < 0.05; **p < 0.01).
(C and D) Effect of PGE2 on cytokine mRNA amounts (C) and protein secretion (D) from bone marrow macrophages (BMMs) treated with LPS (*p < 0.05;
**p < 0.01).
(E) Effect of PGE2 on LPS-induced increases in JNK or P38 activation, IkBa phosphorylation, and p65 acetylation. Cotreatment with increasing concentrations of
PGE2 are indicated.
(F) Chromatin immunoprecipitation (ChIP) assay of p65 recruitment and histone H4K5 acetylation over Tnf-a and Il-12b promoters in BMMs exposed to LPS and
PGE2 (*p < 0.05; **p < 0.01).
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toxin, or edema factor also lowered cytokine gene expression
(Figure S1C).
The TLR signaling pathway has been shown to stimulate a
signaling cascade that culminates in the activation of NF-kB
(Hayden and Ghosh, 2008; Takeda and Akira, 2004). Exposure
to PGE2 did not interfere with the activation of P38 or JNK or
with the phosphorylation of either IkBa or the NF-kB subunit
p65 in response to LPS (Figure 1E), but it blocked LPS-depen-
dent increases in both p65 and histone H4K5 acetylation over
cytokine promoters (Figures 1E and 1F). Consequently, p65
recruitment to the Tnf-a and Il-12b promoters was reduced in
cells cotreated with LPS plus PGE2 compared to LPS alone.CellRole of the CREB/CRTC Pathway in Macrophages
Based on the ability for the CREB/CRTC pathway to stimulate
the expression of the anti-inflammatory cytokine IL10 in macro-
phages (Clark et al., 2012; MacKenzie et al., 2013), we consid-
ered whether cAMP signals inhibit proinflammatory cytokine
production via this mechanism. CRTC2 and CRTC3 were
readily detected in cultured BMMs; they were confined to the
cytoplasm under basal conditions and following exposure to
LPS (Figures S2A and S2B). Cotreatment of LPS with PGE2
agonist triggered CRTC2/3 dephosphorylation and nuclear
translocation. As a result, Il-10 mRNA and protein secretion
were upregulated in wild-type cells exposed to LPS plus
PGE2, but less so in BMMs from Crtc2 knockout (KO) or Crtc3Metabolism 19, 1058–1065, June 3, 2014 ª2014 Elsevier Inc. 1059
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Figure 2. Class IIa HDACs Inhibit Cytokine Gene Expression in Response to cAMP
(A and B) Effect of LPS and PGE2 on HDAC4 dephosphorylation (A) and cellular localization (B). Phospho (Ser246) HDAC4 amounts in control (Hdac4 fl/fl) and
Hdac4 MKO cells exposed to LPS and PGE2 are shown in (A). Amounts of acetylated and total p65 in wild-type and Hdac4 MKO BMMs exposed to LPS plus
PGE2 are indicated. HDAC4 subcellular localization in BMMs exposed to LPS and PGE2 is shown in (B).
(C) ChIP assay showing effects of PGE2 and LPS on HDAC4 recruitment to Tnf-a and Il-12b promoters (*p < 0.05; **p < 0.01).
(D and E) Effect of LPS and PGE2 on p65 occupancy (D) and histone H4K5 acetylation over Tnf-a and Il-12b promoters (E) in BMMs from Hdac4MKO or control
littermates (*p < 0.05; **p < 0.01).
(F) Effect of LPS and rolipram administration on survival (left) and circulating cytokine concentrations (right) in control or Hdac4 MKO mice (n = 12; *p < 0.05;
**p < 0.01).
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Catecholamines Inhibit NF-kB Activity via HDAC4KO mice (Figures S2C and S2D). In keeping with the reduction
in Il-10, Tnf-a, and Il-12b mRNA amounts were increased in
Crtc2 and Crtc3 KO BMMs; we observed similar differences in
Il-10 KO cells (Figures S2F and S2G). Despite these changes,
PGE2 was still effective in blocking p65 promoter recruitment
and in downregulating TNF-a and IL-12b production in Crtc2
KO and Crtc3 KO cells (Figures S2C–S2E). Taken together,
these results suggest that the CREB/CRTC pathway exerts an
anti-inflammatory role in BMMs via its effects on IL-10, but that
a second pathway also mediates effects of cAMP on NF-kB
activity.1060 Cell Metabolism 19, 1058–1065, June 3, 2014 ª2014 Elsevier InClass IIa HDACs Mediate Effects of cAMP
Having seen that exposure to cAMP promotes the deacetylation
of p65 and histone H4K5, we evaluated the potential role of the
cAMP/class IIa HDAC pathway in this setting. Of the three family
members (HDAC4, HDAC5, and HDAC7), HDAC4 is the most
highly expressed in macrophages (Figure S3A). Similar to the
CRTCs, HDAC4 is phosphorylated at consensus SIK recognition
sites and sequestered in the cytoplasm under basal conditions
and following stimulation with LPS (Figures 2A and 2B). Expo-
sure of wild-type BMMs to PGE2 in combination with LPS
triggered HDAC4 dephosphorylation at Ser246 and nuclearc.
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Figure 3. LKB1 Regulates Cytokine Gene
Expression by Modulating HDAC4 Phos-
phorylation
(A and B) Effect of LPS and PGE2 on HDAC4
dephosphorylation (A) and nuclear localization (B)
in control (Stk11 fl/fl) and Stk11 KO BMMs. Phos-
pho (Ser246) HDAC4 protein amounts in Stk11 KO
cells are shown in (A). Amounts of acetylated and
total p65 are indicated.
(C and D) ChIP assays showing HDAC4 (C) and
p65 recruitment (D) to Tnf-a and Il-12b promoters
in control orStk11KOBMMs (*p < 0.05; **p < 0.01).
(E and F) Cytokine mRNA amounts (E) and protein
secretion (F) from BMMs exposed to LPS and
PGE2 as indicated (*p < 0.05; **p < 0.01).
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Il-12b promoters increased in cells treated with PGE2 + LPS
compared to LPS alone (Figure 2C). Based on these effects,
we tested whether HDAC4 associates with p65. Supporting
this idea, we recovered endogenous p65 from immunoprecipita-
tions (IPs) of endogenous HDAC4 that were prepared from
BMMsexposed to LPSandPGE2but not LPSalone (FigureS3C).
We obtained similar results in coIP studies using epitope-tagged
p65 and HDAC4 expression vectors. Consistent with this associ-
ation, overexpression of wild-type and, to a greater extent, phos-
phorylation-defective HDAC4 or HDAC5 decreased NF-kB
reporter activity in cells coexpressing p65 (Figure S3B).
To further evaluate the role of HDAC4 in modulating cytokine
gene expression, we used BMMs from mice with a macro-
phage-specific knockout of Hdac4 (Hdac4 MKO). Exposure of
wild-type or Hdac4 MKO BMMs to LPS alone increased the
acetylation and recruitment of p65 to cytokine promoters
comparably (Figures 2A and 2D). By contrast with the inhibitory
effects of PGE2 in control BMMs, however, exposure to PGE2
did not reduce amounts of acetylated p65 or downregulate
p65 recruitment, and it did not diminish histone H4K5 acetylation
over Tnf-a and Il-12b promoters inHdac4MKO cells (Figures 2A,
2D, and 2E). Consequently, Tnf-a and Il-12b mRNA and protein
secretion were nearly fully rescued in Hdac4 MKO BMMs costi-
mulated with LPS and PGE2 relative to LPS alone (Figures S3D
and S3E).
We examined effects of Hdac4 MKO on the inflammatory
response in vivo. LPS administration increased circulating
concentrations of TNF-a and IL-12b and promoted lethality
comparably in wild-type and Hdac4 MKO mice (Figure 2F).
Although rolipram coadministration improved survival in LPS-
treated control mice, it had modest effects in Hdac4 MKO litter-
mates. These results demonstrate that HDAC4 associates with
and inhibits NF-kB activity in response to cAMP.Cell Metabolism 19, 1058–10Role of SIKs in Regulating Class IIa
HDACs
cAMP has been shown to promote the
dephosphorylation and nuclear shuttling
of class IIa HDACs through PKA-medi-
ated inhibition of the SIKs (Berdeaux
et al., 2007; Mihaylova et al., 2011;
Wang et al., 2011). Based on the impor-
tance of the master kinase LKB1 (Stk11)in activating SIKs, we evaluated effects of Stk11 gene disruption
on HDAC4 activity. Knockout of Stk11 in BMMs led to HDAC4
dephosphorylation and nuclear translocation (Figures 3A and
3B). Indeed, HDAC4 occupancy over the Tnf-a and Il-12b pro-
moters was constitutively elevated in Stk11 mutant cells (Fig-
ure 3C). As a consequence, p65 acetylation and promoter
recruitment were reduced in Stk11 KO BMMs, leading to de-
creases in cytokine production (Figure 3). Indeed, reducing SIK
activity with a small-molecule inhibitor (staurosporine) or by
RNAi-mediated knockdown of SIK expression decreased cyto-
kine gene expression in BMMs exposed to LPS (Figure S4).
These results support the idea that cAMP modulates cytokine
gene expression through inactivation of the LKB1/SIK pathway
and consequent induction of class IIa HDACs.
Role of HDAC4 in Obesity
Overnutrition triggers leptin-mediated increases in sympathetic
nerve activity that stimulate the mobilization of triglycerides
fromadipose. Leptin injection into ob/obmice upregulated circu-
lating concentrations of norepinephrine as well as cAMP content
in epididymal fat pads (Figure 4A). The rise in cAMP appeared to
be catecholamine dependent, because it was blocked by admin-
istration of b-adrenergic antagonist. In keeping with these
effects, leptin administration also promoted HDAC4 dephos-
phorylation inWAT; these effects were propranolol sensitive (Fig-
ure S3H). As a result, leptin stimulated the nuclear translocation
of HDAC4 in adipose-resident macrophages (Figure 4B).
Short-term high-fat diet (HFD) feeding (4 weeks) also triggered
increases in circulating norepinephrine that stimulated the
cAMP-HDAC4 pathway in adipose tissue macrophages (Fig-
ure S3). But long-term (12 weeks) HFD feeding had more
modest effects on HDAC4 dephosphorylation, reflecting in-
creases in leptin resistance that attenuate sympathetic nerve
activity in WAT.65, June 3, 2014 ª2014 Elsevier Inc. 1061
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Figure 4. Insulin Resistance and Obesity in Hdac4 MKO Mice
(A) Circulating norepinephrine concentrations (left) and cAMP content in epididymal fat pads (right) of lean and ob/obmice following intraperitoneal (i.p.) injection
with PBS or leptin (3 mg/g) for 2 hr (n = 3). Effect of propranolol (1 mg/g) i.p. on cAMP content in leptin-treated mice (n = 3) is shown (*p < 0.05; **p < 0.01).
(B) HDAC4 localization in adipose tissue macrophages of lean and ob/obmice. Mice were preinjected with propranolol (1 mg/g) or vehicle i.p. for 1 hr followed by
leptin (3 mg/g) for 2 hr (n = 3). Macrophages were identified by costaining with F4/80 antiserum.
(C) Circulating glucose, insulin, and free fatty acids in Hdac4 MKO compared to control littermates on a HFD for 8 weeks (n = 8; *p < 0.05; **p < 0.01).
(legend continued on next page)
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Catecholamines Inhibit NF-kB Activity via HDAC4Obesity has been shown to promote insulin resistance through
increases in macrophage infiltration into white adipose tissue
and liver (Arkan et al., 2005; Hotamisligil, 2006). Based on its
inhibitory effects on NF-kB activity, we wondered whether the
cAMP-HDAC4 pathway protects against insulin resistance. To
test this notion, we evaluated effects of HFD feeding in Hdac4
MKO versus wild-type littermates. Although they were similar
to controls on normal chow, Hdac4MKO mice had higher circu-
lating glucose and free fatty acid concentrations after 8weeks on
a HFD (Figure 4C). Insulin levels were also elevated in Hdac4
MKO mice; they became glucose intolerant and had reduced
glucose clearance (Figure 4D). Consistent with these profiles,
macrophage infiltrates in WAT and triglyceride accumulation in
liver weremore pronounced in HFD-fedHdac4MKOversus con-
trol mice (Figures 4E and S3).
We tested whether induction of the cAMP pathway im-
proves insulin sensitivity via an HDAC4-dependent mechanism.
Rolipram administration for 7 days improved glucose toler-
ance and insulin sensitivity in wild-type but not Hdac4
MKO littermates under HFD conditions (Figure 4F). These re-
sults demonstrate that HDAC4 acts downstream of cAMP in
macrophages.
Superimposed on these metabolic changes, Hdac4 MKO
mice gained more weight on a HFD, and they had increased
adiposity (Figures 4G and 4H). Indeed, Hdac4 MKO mice had
increased food intake with decreased oxygen consumption as
well as physical activity (Figures S3J and S3K). Realizing that
these increases in body weight could contribute to inflammatory
changes in Hdac4 MKO mice, we evaluated these animals after
4 weeks of HFD feeding, when body weights and adiposity in
Hdac4mutants are comparable to controls (Figure S3L). Consis-
tent with their increases in adipose tissue macrophages, Hdac4
MKO mice were more glucose intolerant and insulin resistant by
GTT and ITT testing.
Based on the effects of HDAC4 in mice, we sought evidence
of a similar role for class IIa HDACs in humans via a two-
stage genetic association study of the Hdac4 (chromosome
2q37.3), Hdac5 (chromosome 17q21), and Hdac7a (chromo-
some 12q13.1) genes, conducted in the Multi-Ethnic Study of
Atherosclerosis (MESA). In the first stage, we assessed associ-
ation of variants in these three genes with body mass index and
waist circumference in 2,268 white subjects. Seventy Hdac4
SNPs were associated with BMI and 44 Hdac4 SNPs were
associated with waist circumference; 30 of these SNPs were
associated with both traits. The number of associations with
BMI was well in excess of the number expected by chance
(70 versus 25, c2 = 19.5, p < 0.0001), as was the number of
SNPs associated with waist circumference (44 versus 25, c2 =
4.9, p = 0.027). On the other hand, only a few (%5) Hdac5
SNPs and no Hdac7a SNPs were associated with these traits.
In the second stage (Tables S1 and S2), we found that a signif-
icant fraction of Hdac4 SNPs associated with BMI and waist
circumference in white subjects were also associated with these(D) Glucose and insulin tolerance testing of Hdac4 MKO and control (Hdac4 fl/fl)
(E) Macrophage infiltration in WAT by immunohistochemical (left) and Q-PCR (rig
(F) Effect of rolipram administration for 7 days on glucose and insulin tolerance
**p < 0.01).
(G and H) Weight gain (G) (n = 8) as well as fat mass (n = 4) and circulating leptin
Celltraits in black and Chinese subjects. Most of these associations
had the same direction of effect as those observed in white sub-
jects. Remarkably, seven SNPs replicated in black subjects
were associated with both BMI and waist circumference; these
SNPs were concentrated in the proximal end of the gene,
particularly in intron 2, suggesting that this region of the gene
harbors a functional variant that influences obesity in white
and black subjects.
Our results demonstrate that increases in sympathetic nerve
activity in response to acute overnutrition trigger the activation
of two cAMP-responsive pathways: the CRTCs and class IIa
HDACs. Both pathways inhibit the production of inflammatory
mediators via induction of IL-10 and repression of NF-kB,
respectively. As IL-10 has also been found to promote insulin
sensitivity in the setting of diet-induced obesity (Hong et al.,
2009), we imagine that the CRTC pathway may have salutary
effects in this context. During the preparation of this manuscript,
Abu-Farha et al. reported that HDAC4 expression is downregu-
lated in adipose from obese subjects (Abu-Farha et al., 2013).
Our results extend these studies by showing that disruption of
Hdac4 in macrophages is sufficient to promote insulin resistance
and obesity.
In addition to HDAC4, a number of regulatory factors including
SirT1 (Schug et al., 2010) and KLF4 (Liao et al., 2011) have been
shown to modulate energy balance through their effects in
macrophages. Alternatively activated M2 macrophages can
modulate energy expenditure by secreting catecholamines and
enhancing brown fat thermogenesis, for example (Nguyen
et al., 2011). It is tempting to speculate that HDAC4 and other
regulators may modulate energy expenditure through effects
on a secreted factor.
EXPERIMENTAL PROCEDURES
Cells
BMMs were prepared from mouse bone marrow cells as described (Wei-
schenfeldt and Porse, 2008).
Mice
C57BL/6J, ob/ob, LysMcre, and Il-10KOmicewere purchased from The Jack-
son Laboratory. Crtc2 and Crtc3 KO mice were described previously (Song
et al., 2010; Wang et al., 2010). In studies with Stk11 KO macrophages,
BMMs from floxed Stk11 mice (Bardeesy et al., 2002) were infected with
cre-expressing or control GAL4-expressing lentivirus. Hdac4 fl/fl mice have
been described (Vega et al., 2004). Sik3 KOmice (Uebi et al., 2012) were kindly
provided by Hiroshi Takemori (Osaka). Floxed Hdac4 mice (Potthoff et al.,
2007) were provided by Eric Olson (UTSW). Macrophage-specific KO of
Hdac4 was obtained by a two-step cross of Hdac4 fl/fl mice with LysMcre
mice. All animal procedures were performed with an approved protocol from
the Salk Institute Animal Care and Use Committee.
Cytokine and Metabolite Analysis
Mice were injected with LPS (30 mg/kg) with or without rolipram (5 mg/kg) for
16 hr, and serum was obtained through cardiac puncture. BMMs were stimu-
lated with LPS (10 ng/ml) with or without PGE2 (100 nM) for 16 hr, and super-
natant was collected.mice on a HFD for 8 weeks (n = 8; *p < 0.05; **p < 0.01).
ht) analyses (*p < 0.05; **p < 0.01).
in wild-type and Hdac4 MKO mice on a HFD for 12 weeks (n = 6; *p < 0.05;
levels (n = 8) (H) in Hdac4 MKO and control littermates (*p < 0.05; **p < 0.01).
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For glucose tolerance testing, mice were fasted for 16 hr and then injected
intraperitoneally (i.p.) with glucose (1.5 g/kg). For insulin tolerance testing,
mice were fasted for 2 hr and injected i.p. with insulin (Humulin; 1 U/kg). Roli-
pram (5 mg/kg/day) was injected i.p. for 7 days. Blood was collected from the
tail vein, and glucose levels weremeasured with a OneTouch Ultra Glucometer
(Johnson & Johnson).
Histology
Tissues were fixed and paraffin embedded. Sections (5 mm) were used for
hematoxylin and eosin staining or immunohistochemistry. For studies with
adipose tissue macrophages, rehydrated antigen-retrieved sections were
incubated with F4/80 (Abcam) antiserum and visualized by the avidin-biotin-
complex method using diaminobenzidine (Vector Labs).
Chromatin Immunoprecipitation
BMMs were plated in 150 mm plates and exposed to LPS (10 ng/ml) with or
without PGE2 (100 nM) for 1 hr. ChIP assays were performed as described
(Screaton et al., 2004). RNA was isolated by RNeasy kit (QIAGEN). Primer
sequences are shown in Table S3.
Blotting and Immunostaining
Immunoblot, immunoprecipitation, and immunostaining assays were per-
formed as described (Altarejos et al., 2008). Anti-CRTC2 antibodies were
described previously (Koo et al., 2005).
Luciferase Reporter Assay
HEK293T cells were transfected with NF-kB-Luc reporter, RSV-bgal, and indi-
cated plasmids for 48 hr, and luciferase assays were performed (Liu et al.,
2008).
Statistical Analyses
All studies were performed on at least three independent occasions. Results
are reported as mean ± SEM. The comparison of different groups was carried
out using two-tailed unpaired Student’s t test or two-way ANOVA test. Differ-
ences were considered statistically significant at *p < 0.05 and **p < 0.01.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2014.03.024.
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